DORMICUM

This brand name is authorized in Austria, Croatia, Ecuador, Estonia, Finland, Hong Kong SAR China, Lithuania, Mexico, Netherlands, Poland, Singapore, South Africa, Spain.

Active ingredients

The drug DORMICUM contains one active pharmaceutical ingredient (API):

1	Midazolam UNII W7TTW573JJ - MIDAZOLAM HYDROCHLORIDE
	Midazolam is a derivative of the imidazobenzodiazepine group. The free base is a lipophilic substance with low solubility in water. The basic nitrogen in position 2 of the imidazobenzodiazepine ring system enables the active ingredient of midazolam to form water-soluble salts with acids.
	Read more about Midazolam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05CD08	Midazolam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.249-1-02-12, 24.279-1-02-12, 24.314-1-02-12
EE	Ravimiamet	1000663, 1006085, 1164822, 1811191, 1848135
ES	Centro de información online de medicamentos de la AEMPS	59023
FI	Lääkealan turvallisuus- ja kehittämiskeskus	066589, 436188
HK	Department of Health Drug Office	20343, 25854, 32941, 60756
HR	Agencija za lijekove i medicinske proizvode	HR-H-891560860, HR-H-950365768
LT	Valstybinė vaistų kontrolės tarnyba	1021245, 1021246
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	138M83, 284M87
NL	Z-Index G-Standaard	14179091, 14179105
NL	Z-Index G-Standaard, PRK	22977, 30082, 93645, 93653
PL	Rejestru Produktów Leczniczych	100020459, 100020471
SG	Health Sciences Authority	00476P, 00478P, 03800P
ZA	Health Products Regulatory Authority	Q/2.2/286, R/2.2/123, T/2.2/0207, Y/2.2/325